Biofrontera AG buy krebskrebs
Start price
16.08.21
/
50%
€2.49
Target price
16.08.22
€4.00
Performance (%)
-50.80%
End price
17.08.22
€1.23
Summary
This prediction ended on 17.08.22 with a price of €1.23. The BUY prediction by krebskrebs for Biofrontera AG performed very badly with a performance of -50.80%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biofrontera AG | - | - | - | - |
| iShares Core DAX® | 2.554% | -0.112% | 14.995% | 49.597% |
| iShares Nasdaq 100 | 2.742% | -0.470% | 30.954% | 80.868% |
| iShares Nikkei 225® | 6.584% | 3.221% | 49.697% | 60.373% |
| iShares S&P 500 | 1.930% | -0.519% | 24.883% | 60.000% |
Comments by krebskrebs for this prediction
In the thread Biofrontera AG diskutieren
In the thread Trading Biofrontera AG
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten